Abstract | PURPOSE: OBJECT AND METHOD: The questionnaire survey was conducted about the MDR-TB patients and their contacts examination enforced in the ordinance-designated cities in Japan from 1998 to 2002. RESULT: Nine cities out of total 13 ordinance-designated cities replied to the questionnaire (69.2%). The cases newly diagnosed as MDR- pulmonary tuberculosis were 189 cases from 1998 to 2002. Out of 189 cases, 34 MDR pulmonary tuberculosis patients were the source of MDR-TB infection. Among 659 individuals who were exposed to 34 MDR-TB, 58 persons (8.8%) were diagnosed as the contacts who were infected with MDR-TB. Out of 58 persons, 41 had chemoprophylaxis; 18 with isoniazid (INH), 3 with Ethionamide (TH), 2 with INH + Rifampin (RFP) + Ethambutol (EB), and each one with EB + Pyrazinamide (PZA) + TH, PZA + TH, PZA + Levofloxacin, PZA + EB. In 6 persons, INH was changed to other medicines, and 8 persons were treated with unknown prescription. Thirteen contacts developed MDR-TB, and out of them, 9 cases had several problems when they developed MDR-TB. Those problems were the delay in detection, infection from hospitalization refused cases, infection at the time of bacteriological relapse, and no use of chemoprophylaxis. CONCLUSION: MDR-TB bacilli produce the tuberculosis infection similarly as the sensitive tubercle bacilli, and it is necessary to re-examine the action plan of contacts examination including chemoprophylaxis.
|
Authors | Yuka Sasaki, Fumio Yamagishi, Takenori Yagi |
Journal | Kekkaku : [Tuberculosis]
(Kekkaku)
Vol. 80
Issue 10
Pg. 637-42
(Oct 2005)
ISSN: 0022-9776 [Print] Japan |
PMID | 16296391
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Antitubercular Agents
(administration & dosage)
- Child
- Child, Preschool
- Community Health Centers
- Female
- Humans
- Japan
(epidemiology)
- Male
- Middle Aged
- Sex Factors
- Surveys and Questionnaires
- Time Factors
- Tuberculosis, Multidrug-Resistant
(epidemiology, prevention & control, transmission)
|